|
| |
Third Wave TechnologiesThird Wave is a growing leader in molecular diagnostics, providing DNA and RNA analysis products to clinical, research, and agricultural customers. Our company is one of the only companies in the molecular diagnostics market with a unique chemistry—the functional backbone of any molecular test. We are commercializing this unique chemistry to capture opportunities in this growth market.
We have 150-160 clinical testing customers and the list continues to grow. In the United States, we serve most major clinical laboratories that perform tests in the molecular diagnostics testing market. Third Wave has also established a strong presence in Japan.
Our Invader® chemistry is well recognized and widely used. Our clinical diagnostic products are used by clinical testing laboratories to create tests for prognosis, diagnosis, and monitoring by physicians of individual patients. In addition to molecular diagnostics, we support world-renowned researchers looking to improve the identification and management of disease, as well as agricultural customers in plant and animal genetics and diagnostics.
Third Wave's facilities include GMP manufacturing, product development, and customer and technical services. Third Wave has achieved ISO 13485:2003 certification, a stringent, globally recognized standard of quality management.
| Contact Details: |
| 502 S. Rosa Road |
| Madison |
| WI |
| 53719 |
| United States of America |
| Tel: | 608-273-8933 or 888.898.2357 |
| Fax: | 608-273-8618 |
| Email: | techserv@twt.com |
| WWW: | www.twt.com/
|
|
Loading...
|
Recent Publications by Third Wave Technologies: |  |
Invader assay for single-nucleotide polymorphism genotyping and gene copy number evaluation.
The Invader assay (Third Wave Technologies) is a homogeneous, isothermal... | 12th October, 2007
| Third Wave Technologies Inc., Madison, WI, USA.
| Methods Mol Biol. 2006;335:173-86.
DOI Direct Link |
RanBP2 modulates Cox11 and hexokinase I activities and haploinsufficiency of RanBP2 causes deficits in glucose metabolism.
The Ran-binding protein 2 (RanBP2) is a large multimodular and pleiotropic... | 22nd December, 2006
| Third Wave Technologies, Madison, Wisconsin, United States of America.
| PLoS Genet. 2006 Oct;2(10):e177. Epub 2006 Sep 1.
DOI Direct Link |
Invader plus method detects herpes simplex virus in cerebrospinal fluid and simultaneously differentiates types 1 and 2.
We report here on the development and validation of a prototype Invader... | 28th October, 2006
| Third Wave Technologies, Inc., 502 South Rosa Rd., Madison, WI 53719, USA.
| J Clin Microbiol. 2006 Sep;44(9):3443-7.
DOI Direct Link |
Quantitation of microRNAs using a modified Invader assay.
The short lengths of microRNAs (miRNAs) present a significant challenge... | 24th August, 2004
| Third Wave Technologies, Inc., 502 South Rosa Rd., Madison, WI 53719, USA.
| RNA. 2004 Jul;10(7):1153-61.
DOI Direct Link |
Invader assay for RNA quantitation.
The Invader assay is a homogeneous, isothermal, signal amplification... | 14th May, 2004
| Third Wave Technologies Inc., Madison, WI, USA.
| Methods Mol Biol. 2004;258:53-69.
DOI Direct Link |
→View more Third Wave Technologies research publications. |
Press Releases on Third Wave Technologies:
|
 |
| Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results |
9th November, 2009 |
Hologic, Inc. |
-- Term loan to fund the Third Wave Technologies acquisition reduced from
an initial balance of $540 million at July 24, 2008 to $174.2 million as
of September 26, 2009 and
|
| Reportlinker Adds Molecular Diagnostics: A Dynamic and Rapidly Broadening Market |
29th October, 2009 |
Reportlinker |
-- Major trends in the molecular diagnostics market, such as the increasing
number of tests that are commercially available
Chapter 1
BACKGROUND AND SCOPE
1.1. Background
1.2. Focus
|
| Reportlinker Adds In Vitro Diagnostics US Market Report |
1st October, 2009 |
Reportlinker |
NEW YORK, Oct. 1 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue.
In Vitro Diagnostics US Market
http://www.reportlinker.com/p0109780/In
|
| Reportlinker Adds Who's Doing What in Molecular Diagnostics? - Kalorama / Emmes Survey of US Laboratories Report |
24th September, 2009 |
Reportlinker |
-- Communicable Diseases - CMV (Cytomegalovirus), EBV (Epstein-Barr Virus),
Group B Strep, Enterovirus
What Labs Do Now, What They are Planning in the Future
There has been much analysis
|
| SeqWright's Clinical Trial Support Contributes to the Approval of Two HPV Diagnostic Systems |
7th April, 2009 |
SeqWright Inc. |
HOUSTON, April 7 /PRNewswire/ -- SeqWright Inc., an international leader in the field of contract genomic services, announced today its involvement in Hologic's (formerly Third Wave Technologies)
|
 Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 589 times since April 2007, the link to the organisation's website has been followed 92 times Recent Search Terms used to find this page: 502 S. Rosa Road Madison, WI 53719 | Third Wave Technologies 2008 | Invader Functional Assay licensing hologic | Hologic CMV | Hologic Inc. Madison WI 53719 USA. | invader assay third wave hologic | Invader assay for RNA quantitation. Methods Mol Biol. 2004 258 53-69 | Third Wave Technologies Inc madison | Hologic Inc Invader assay | Hologic Inc Invader assay | . Search for more companies in Madison Search for more companies in WI This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for Third Wave Technologies |
